Walgreens Boots Alliance (WBA) has agreed to pay up to $350 million to settle claims it played a role in the US opioid crisis, the Department of Justice said Monday.
The Justice Department alleged that Walgreens and its subsidiaries illegally filled millions of invalid prescriptions for opioids and other controlled substances and then sought payment for many of those invalid prescriptions from the federal government.
The alleged practice took place from August 2012 through March 1, 2023, the Justice Department said.
The $350 million settlement is made up of a $300 million payment plus a further $50 million if Walgreens is sold, merged, or transferred before fiscal 2032.
"The settlement amount is based on Walgreens's ability to pay," the Justice Department said.
Walgreens also agreed to implement certain compliance measures to ensure it meets the law when dispensing controlled substances, the Justice Department said.
The Justice Department added that its claims were allegations only and there had been no determination of liability.
Walgreens did not immediately respond to a request for comment from MT Newswires.
Price: 10.85, Change: -0.04, Percent Change: -0.41
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。